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At the time of writing, the World Health Organisation has declared COVID-19 (novel 
corona virus) a pandemic and health-care systems around the world face the biggest 
public health challenge for a generation. As never before, the clinical and scientific 
communities, governments and the public need access to robust data to facilitate 
evidence-based decision making. The foundation of a reliable research literature is 
effective peer review. However, in the last decade, there has been debate over the 
effectiveness of peer review. Research in the field has shown that prestigious 
journals reject manuscripts which go on to be highly cited elsewhere1. The peer 
review process introduces considerable delay in making research findings publicly 
available2 and yet there is no correlation between the number of rounds of 
manuscript review and revision and the subsequent citation count for the paper1. 
 
The stage is therefore set for the entrance of a new actor – the preprint server. A 
recent article (posted as a preprint) identified almost 50 preprint servers, open 
research bundles or other disruptive technologies which have entered the field in 
recent years3. The distinctive feature of preprint servers is that they do not undertake 
peer review but restrict scrutiny to basic screening and legal checks, such as for 
plagiarism. However, preprint servers do allow online comments from the scientific 
community – a form of “crowd-sourced” peer review. Substantive comments can 
allow the amendment of the manuscript before subsequent submission to a 
conventional peer-reviewed journal. 
 
One of the first such preprint servers was arXiv (founded in 1991) to serve the 
physics, astronomy and mathematics research communities. The established player 
in the life sciences field is bioRxiv, founded in 2013 and currently hosting almost 
80,000 articles. The new kid on the block serves medical sciences: medRxiv was 
launched in June 20194 and is currently hosting more than 2,500 articles (including 
over 850 on COVID-19). 
 
At Thorax we embrace this new pathway to publishing medical research findings and 
we welcome the submission of manuscripts which have previously appeared on a 
preprint server. We do, however, ask all submitting authors to make this clear in the 
covering letter at the time of submission. The first batch of 10 articles, which 
previously appeared as preprints, have been through peer review with Thorax. The 
acceptance of articles which have previously appeared as a preprint is now 
widespread amongst medical journals5,6. Acceptance of preprints is, however, not 
universal and authors are well advised to check the guidelines of their target journals 
before they post a preprint.  
 
So do preprint servers live up to the hype? Do they allow “just in time delivery” for 
science? Are they an innovation whose hour has come during a public health crisis 
such as the COVID-19 pandemic? In medicine (as distinct from the life sciences) 
there are some declared limitations. MedRxiv carries a disclaimer on its home page 
which says that preprints: “…should not be relied on to guide clinical practice or 
health-related behaviour and should not be reported in news media as established 
information.” The editor of one leading medical journal has previously suggested, 
with reference to preprints, that the “…rush to publication…” is an “… editorial and 
scientific mistake…” 7. This assertion is supported by the fate of a recent preprint, 
suggesting similarities between the novel coronavirus and HIV virions8. This preprint 
was withdrawn, after receiving over a hundred (mostly critical) online comments – 
although it could be argued that this represents effective, informal peer-review. 
Retraction of a misleading article, published in a conventional journal, would have 
taken a lot longer. However, some data suggest that there is little time for this 
informal peer review. Some journals are publishing articles only a few months after 
their appearace on bioRxiv9 – suggesting that journal submission occurs shortly after 
preprint posting. This would leave little time for feedback on the preprint to allow 
amendment or correction prior to journal submission. 
 
It has also been suggested that preprints have helped to drive the early discourse 
and have influenced policy-making at the start of the COVID-19 pandemic10. The UK 
government cited a preprint in their first coronavirus action plan11. There has been 
an exponential rise in preprint articles deposited during the pandemic12 reflecting the 
urgent need and desire for the latest information. In the face of a pandemic such as 
COVID-19, “just in time delivery” is critical for research. Indeed, preprint servers 
allowed the rapid publication of data used to allow vital modelling the trajectory of the 
pandemic13. 
 
Both traditional publishers and preprint servers are adapting to the demand for rapid 
access to data on COVID-19. Many traditional journals are fast tracking COVID-19 
publications with over 300 published already this year12 and medRxiv has been more 
sympathetic to studies with a small number of participants because clinical data have 
not been available in any other form.  
 
In due course, when the COVID-19 curve (flattened or otherwise) hits baseline, 
researchers and journals must use the preprint literature wisely and as it is intended 
– as a way to share research data rapidly before formal expert review in a journal. 
Any individual claims should be treated with healthy scepticism, until verified by peer 
review. Such scepticism can be difficult in the current frenzied environment. 
Therefore, it is vital that the research community does not misuse the benefits of 
preprints to short-circuit the quality controls that drive peer reviewed publication. 
Similarly, it is crucial that journals streamline, but maintain high-quality peer review 
processes, and in times of crisis make content free to access. At Thorax we are 
committed to supporting preprints whilst continuing to provide robust, rapid and fair 
peer review to maintain confidence in the quality of the published work.  
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